January 29, 2008 — Medtronic, Inc. (NYSE: MDT) announced the FDA approval of a new physician-use continuous glucose monitoring (CGM) system, the CGMS® iPro™ Recorder. Physicians send patients home with the CGMS iPro Recorder to uncover patterns and potential problems that often go undetected with today’s standard glucose measurements like finger stick meters and HbA1c tests... Medtronic's Press Release-
Thursday, January 31, 2008
Medtronic, FDA Approval of CGMS iPro Continuous Glucose Recorder
January 29, 2008 — Medtronic, Inc. (NYSE: MDT) announced the FDA approval of a new physician-use continuous glucose monitoring (CGM) system, the CGMS® iPro™ Recorder. Physicians send patients home with the CGMS iPro Recorder to uncover patterns and potential problems that often go undetected with today’s standard glucose measurements like finger stick meters and HbA1c tests... Medtronic's Press Release-
